Senzime AB (publ) (SNZZF) Q4 2025 Earnings Call Prepared Remarks Transcript

Core Insights - Senzime experienced accelerated growth in 2025, achieving a revenue increase of approximately 90% in constant currencies, surpassing SEK 110 million in guidance [2][3] - The company aims to reach positive cash flow by 2026, supported by continued growth and stringent cost control measures [2] Financial Performance - In Q4 2025, Senzime reported revenues of SEK 28.3 million, which translates to SEK 31.2 million in constant currencies, marking more than a doubling of business compared to the previous year [3] - The underlying gross margin improved, operating expenses remained stable, and adjusted EBITDA increased by about 16% [2] Product Development and Market Expansion - The growth in Q4 was driven by significant hospital wins and strong sensor growth, alongside new regulatory approvals in Japan [3] - The company launched the EMGINE software suite and continued to expand its installed base of TetraGraphs, shipping 2,139 units throughout the year, primarily the next-generation TetraGraph [4]